🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on messaging platforms, based on recent findings.

Experimental Treatment Gaining Popularity Online

The experimental drug, which is still in research studies, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to message these profiles directly for supplier links, while also obtaining discount codes.

Thriving Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day British shipping. Vendors market the substance there before directing customers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Experts Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what remains an unlicensed medication in the UK is a cause for concern and could lead to individuals administering substances of uncertain source.

Several experts stated the popularity for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or supplied for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still violate medicines, marketing, and customer regulations, risking penalties, legal action or imprisonment.

Service Reaction and Material Removal

According to the social media company, the service has taken down problematic material and prohibited related keywords and query recommendations. The company stated it was committed to maintaining the service secure and investing in strengthening enforcement strategies.

Digital Marketplace Operations

Investigations also found groups with up to nine thousand participants marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of users, filled with photos of slimming results, glowing reviews and step-by-step guides for mixing or injecting at residence.

After minutes of entering one group, a seller shared WhatsApp details, where the majority of transactions occur. The seller sent an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.

Product Information and Pricing

Inside these groups, messages show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at home with purified liquid, or pre-filled injectors typically priced at 160 pounds for 20 milligrams. When asked how long a pen should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service said it regularly moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are administering materials they cannot confirm. Although the research behind retatrutide is valid, these online versions may not include what they claim,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But fake treatments are highly dangerous. You cannot know what’s contained or whether the environment they were made in was sterile,” she said.

Her team has already encountered individuals harmed by personal administration from unverified suppliers. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority globally. “Therefore at this time no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a company investigational substance not yet authorized … may expose patients to possibly serious health risks”.